Searchable abstracts of presentations at key conferences in endocrinology

ea0011s106 | Presenting your research – getting your work known | ECE2006

Talking to a lay audience

Parkhill TR

The public’s understanding of current scientific matters is mostly communicated through the news media. Scientists and clinicians are often reluctant to comment to the press, largely through a fear of these comments being taken out of context. The news media tries to balance reports by taking comment from different sides of the story; if scientists and clinicians do not put their views forward, this void is often rapidly filled by someone with a stronger opinion, for exam...

ea0012p63 | Endocrine tumours and neoplasia | SFE2006

Spindle epithelial thyroid tumour with thymus-like differentiation (SETTLE) in a six year old boy: a case report

Kurzawinski TR , Fulmali A , Ramsay A , Muller W , Gallimore A

We present a case of a six year old boy with an enlarging thyroid mass. He was asymptomatic, euthyroid and had no family history of thyroid disease.Examination and neck ultrasound showed hard mass replacing left thyroid lobe with no lymphadenopathy. FNA cytology suggested diagnosis of lymphoepithelial cyst of the thyroid.Left hemithyroidectomy and isthmusectomy was performed. At operation no lymphadenopathy was seen and right thyro...

ea0011oc59 | ThyroidOC57 British Thyroid Association Award | ECE2006

Tri-iodothyronine improves haemodynamic performance and is associated with improved myocardial protection post on-pump coronary artery bypass grafting

Ranasinghe AM , Quinn DW , Graham TR , Keogh BE , Mascaro CJ , Rooney SJ , Wilson IC , Pagano D , Franklyn JA , Bonser RS

Objectives: Tri-iodothyronine (T3) can improve cardiovascular performance following cardiac surgery. Its effects on myocardial protection are unknown.Methods: We performed two consecutive randomised double-blind placebo-controlled trials (identical management protocols) on patients undergoing first time isolated elective or urgent on-pump coronary artery bypass graft surgery (CABG). Between January 2000 and September 2004, 440 patients were re...

ea0065p85 | Bone and calcium | SFEBES2019

The use of 2D-computed tomography scan as a first-line imaging modality in primary hyperparathyroidism

de Jong MC , Hussein Ziad , Jamal K , Morley S , Beale T , Jawad S , Abdel-Aziz TE , Chung TT , Baldeweg SE , Simpson HL , Srirangalingam U , Kurzawinski TR

Background: Minimally invasive parathyroidectomy relies on accurate localisation of the culprit gland. Combination of US plus Technetium 99m-sestamibi is considered the gold standard. CT parathyroid is thought to be a valuable tool in the pre-operative localisation.Aim: To evaluate the diagnostic performance of 2D CT parathyroid in patients with primary hyperparathyroidism (PHP).Methods: This was a single-institution prospective st...

ea0049ep48 | Adrenal cortex (to include Cushing's) | ECE2017

Late night salivary cortisol measurement may help in excluding Cushing’s syndrome in patients with chronic kidney disease

Ambroziak Urszula , Kondracka Agnieszka , Rojek-Trębicka Jadwiga , Gajkowski Paweł , Stańczyk Agnieszka , Stępor Malwina , Bednarczuk Tomasz

Objective: The diagnosis of Cushing’s syndrome may be challenging, especially in cases of patients with chronic kidney disease (CKD).Aim: The assessment of late night salivary cortisol concentration, serum and salivary concentration in overnight dexamethasone suppression test in patients with CKD stage III–V and a control group.Patients and methods: 37 patients mean age 66±12 (M=13) with CKD stage III–V...

ea0011oc56 | Calcium and bone OC49 Novartis Oncology Young Investigator Award | ECE2006

The Scandinavian investigation of primary hyperparathyroidism (pHPT) – end of inclusion and preliminary results

Bollerslev JB , Jansson SJ , Mollerup CLM , Nordenström JN , Lungren EL , Tørring OT , Franco CF , Varhaug JEV , Isaksen GAI , Rosen TR

Background: From 1999 to the end of June 2005, 186 patients (26 men) with truly asymptomatic pHPT based on the NIH 1990 criteria were included at 11 centres in Scandinavia. The mean age at inclusion was 63.2±7.8 (S.D.) years. After informed consent the patients were randomised to operation (93) or medical observation (94), in order to investigate the effect of operation on Quality of Life and co-morbidity. At present, 159 patients are ongoing, 3 dead, and 2...